Heart Pump Correction: Abiomed Updates Use Instructions for Impella RP with SmartAssist Devices
FDA Approves First New Molecular Entity Under National Priority Voucher Program
FDA Approves First New Molecular Entity Under National Priority Voucher Program
http://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program
Aphreseller (Buy-herbal.com) Issues Voluntary Nationwide Recall of Kian Pee Wan Capsules Due the Presence of Undeclared Dexamethasone and Cyproheptadine
FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-severe-leukocyte-adhesion-deficiency-type-i
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
http://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-neurologic-manifestations-hunter-syndrome
Cryoprobe Recall: Erbe USA Removes Flexible Cryoprobes
Heating Pad Recall: Navajo Manufacturing Company Removes Handy Solutions Neck & Shoulders Heating Pad
Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 g/100mL (NDC 70121-1720-3) Due to a Product Mix-up with Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
http://www.fda.gov/news-events/press-announcements/fda-schedules-public-meeting-commissioners-national-priority-voucher-pilot-program